Special Issue "Cancer and Glycosylation"
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (31 March 2016)
Prof. Dr. Franz-Georg Hanisch
Evidence has accumulated that carbohydrate-peptide epitopes do play a role in classical MHC-mediated immune responses. T-cell recognition of O-glycosylated peptides is potentially of high biomedical significance, because it can mediate the immune protection against microorganisms, and in particular the vaccination in anti-tumor therapies.
Research over three decades has revealed a series of tumor target antigens with proven potential in clinical diagnostics or in immunotherapeutic approaches. Among these are the Carcinoembryonic Antigen (CEA), the ovarian carcinoma marker CA125 (MUC16), and the epithelial tumor markers MUC1 and HER2neu. A common feature of the epithelial tumor markers is that they belong to the family of glycoproteins.
Tremendous progress has been made in recent years with respect to the mass spectrometric elucidation of site-specific glycosylation of proteins and to cancer-associated aspects of immunology, including the search for new markers in tumor diagnostics and the development of mucin glycopeptide-based cancer vaccines.
The purpose of this Special Issue is to convey the latest advances toward an understanding of the multiple roles N- and in particular O-glycosylation might play in epithelial cancers. Particular emphasis will be layed on mucin-linked epitopes in diagnostics and in the development of therapeutics, like those based on MUC1-glycopeptides in the context of active specific immunization.
We look forward to reading your contributions,
Prof. Dr. Franz-Georg Hanisch
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 650 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- epithelial cancer
- inflammation and cancer progression
- breast cancer vaccines
- tumor evasion